Skip to main content

Select Drug Profiles

Cardiometabolic Health in 2014: Clinical and Economic Implications

Dalia Buffery, MA, ABD

Practice Management

Impact of the New ACC/AHA Guidelines on the Treatment of High Blood Cholesterol in a Managed Care Setting

Paul S Chan, MD, MSc, Heidi C. Lew, PharmD, Toros Cagla PhD, Brian K. Solow, MD, FAAFP, Karen M. Stockl, PharmD, Josephine N. Tran, PharmD, MS

Stakeholder Perspective

Real-World Consequences of the 2013 ACC/AHA Cholesterol Guidelines for the Prevention of Cardiovascular Disease

by Joseph D. Jackson, PhD

Original Research

Utilization of Parenteral Anticoagulants and Warfarin: Impact on the Risk of Venous Thromboembolism Recurrence in the Outpatient Setting

Jennifer Cai, MS, MPH, Winghan Jacqueline Kwong, PharmD, PhD, Ronald Preblick, PharmD, MPH, Qiaoyi Zhang, MD, PhD

Stakeholder Perspective

Better Compliance with Clinical Guidelines for Venous Thromboembolism Can Improve Patient Outcomes, Reduce Costs

by James T. Kenney, RPh, MBA

Original Research

New and Emerging Drugs and Targets for Type 2 Diabetes: Reviewing the Evidence

Charles Jia-Haur Hu, DO, Chihyi Lin, DO, Brien Rex Miller, DO, Hanh Nguyen, DO, Quang T. Nguyen, DO, FACE, FTOS

Stakeholder Perspective

Addressing Adherence a Key Challenge in the Management of Patients with Type 2 Diabetes

by Jeffrey A. Bourret, PharmD

Payer Coverage in Polycythemia Vera

Ken Schaecher, MD

Optimal Value-Based Therapy

Ken Schaecher, MD

Costs of Treatment in Polycythemia Vera

Ken Schaecher, MD

Payer Tools for Patient Care

Ken Schaecher, MD

Managing Oncology Costs in Polycythemia Vera

Ken Schaecher, MD

Affordable High Quality Care for Patients

Ken Schaecher, MD

Page 143 of 244
Results 1421 - 1430 of 2438